Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.

Arthritis and Rheumatism
E C Arner, M A Pratta

Abstract

Exposure of bovine nasal cartilage in culture to interleukin-1 (IL-1) leads to a time- and concentration-dependent stimulation of proteoglycan breakdown and prostaglandin E2 (PGE2) release, and to inhibition of proteoglycan synthesis. The threshold levels of IL-1 required for initiating these effects were different, and IL-1 was 10 times more potent in inhibiting synthesis than in stimulating breakdown of proteoglycan. Kinetic studies indicated that the effects on proteoglycan metabolism occurred earlier (16-24 hours) than those for PGE2 release (48 hours). Selective effects were observed with inhibitors. Nonsteroidal antiinflammatory drugs blocked PGE2 production in response to IL-1, but had no effect on proteoglycan metabolism, and the antiarthritic drugs that blocked IL-1-stimulated breakdown augmented the inhibition of proteoglycan synthesis. We suggest that the effects of IL-1 on proteoglycan breakdown, proteoglycan synthesis, and PGE2 release are mediated by independent post-receptor mechanisms.

References

Jan 1, 1988·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J R HubbardC B Sledge
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E R PettipherB Henderson
Jul 1, 1987·Annals of the Rheumatic Diseases·J T DingleD R Bard
Jan 1, 1985·Cellular Immunology·H J RichardsonR G Russell
Aug 1, 1985·Arthritis and Rheumatism·D D WoodD Hamerman
Jul 1, 1972·The Journal of Experimental Medicine·I GeryB H Waksman
Jan 1, 1982·Connective Tissue Research·R W FarndaleA J Barrett
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S B MizelS E Mergenhagen
Feb 1, 1983·The Journal of Experimental Medicine·A E PostlethwaiteA H Kang
Jan 1, 1984·Connective Tissue Research·J T Dingle
Aug 1, 1983·Arthritis and Rheumatism·D D WoodP L Cohen
Jun 1, 1984·Arthritis and Rheumatism·M B McGuire-GoldringR G Russell
Oct 1, 1982·Annals of the Rheumatic Diseases·H SheppeardJ T Dingle

❮ Previous
Next ❯

Citations

Jan 1, 1994·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·M L CameronC H Evans
Apr 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·K FukudaS Tanaka
Dec 20, 2007·Modern Rheumatology·Mika KohnoTakayuki Sumida
Mar 1, 1995·Bioorganic & Medicinal Chemistry·S W WrightM A Pratta
Jun 1, 1996·Bioorganic & Medicinal Chemistry·S W WrightE C Arner
Mar 12, 2004·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Masaaki NishimuraKazumza Fujimura
Jun 11, 2005·Life Sciences·A M PanicoG Ronsisvalle
Sep 6, 2002·Journal of Veterinary Pharmacology and Therapeutics·S P FreanP Lees
Nov 27, 2004·Spine·Koichi MasudaHoward S An
Nov 1, 1995·Annals of the Rheumatic Diseases·J A QuayleS W Edwards
Aug 14, 2008·Arthritis Research & Therapy·Masako UchiiIchiro Miki
May 15, 1993·Experientia·J J Nietfeld
Sep 29, 2011·The Orthopedic Clinics of North America·Won C Bae, Koichi Masuda
Sep 11, 2004·Biochemical and Biophysical Research Communications·Seong-Hyun HoJong-Mook Kim
Dec 1, 1991·Burns : Journal of the International Society for Burn Injuries·H G GargJ P Remensnyder
Sep 18, 2002·The Tohoku Journal of Experimental Medicine·Satoshi YoshidaTadashi Shimamura
Mar 1, 1997·Osteoarthritis and Cartilage·D MargerieE Bartnik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.